CombiMatrix Wraps up Busy Q2 with New Dx Partnership and $2.9M Stock Offering | GenomeWeb

CombiMatrix ended a busy second quarter last week with a new diagnostic partner and $2.9 million extra in the bank.

The company announced that it will co-develop a point-of-care diagnostic with Swiss semiconductor giant ST Microelectronics. Separately, CombiMatrix said it closed a direct stock offering for $2.9 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.